Article
Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.
Arthritis & rheumatology (Hoboken, N.J.) - 1 Aug 2017
Gao Lin, Bird Anna K, Meednu Nida, Dauenhauer Kristin, Liesveld Jane, Anolik Jennifer, Looney R John
Abstract excerpt
OBJECTIVE: Bone marrow-derived mesenchymal stem cells (BM-MSCs) create a special microenvironment for hematopoiesis and immunity and display robust immunomodulatory properties that are impaired in systemic lupus erythematosus (SLE). This study was undertaken to identify the mechanisms of defects in human SLE BM-MSCs. METHODS: Patients fulfilling SLE classification criteria and healthy controls (n = 6 per group)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
